22-100
Showing 1 - 25 of >10,000
Mastectomy; Lymphedema, Anesthesia, Local, Surgery Trial in Erzurum (bupivacaine, 22 gauge 100 mm needle, Propofol)
Completed
- Mastectomy; Lymphedema
- +2 more
- bupivacaine
- +3 more
-
Erzurum, string:Turkey, TurkeyMehmet Aksoy
Apr 14, 2022
Spastic Cerebral Palsy Trial (IncobotulinumtoxinA 100 UNT [Xeomin])
Not yet recruiting
- Spastic Cerebral Palsy
- IncobotulinumtoxinA 100 UNT [Xeomin]
- (no location specified)
Apr 14, 2022
Hearing Loss, Bilateral, Hearing Loss, Unilateral Trial in Oldenburg (Measures of speech intelligibility in a noisy situation
Recruiting
- Hearing Loss, Bilateral
- Hearing Loss, Unilateral
- Measures of speech intelligibility in a noisy situation with speech from the side and from behind (measured with CC-OLSA Test)
- +3 more
-
Oldenburg, Niedersachsen, GermanyHörzentrum Oldenburg gGmbH
Feb 1, 2023
Asthma Trial in Nyíregyháza (Administration via pressurized metered dose inhaler (pMDI))
Recruiting
- Asthma
- Administration via pressurized metered dose inhaler (pMDI)
-
Nyíregyháza, HungarySimplex Kft
Mar 14, 2022
Comparative Bioavailability Trial in Erfurt (GLA-015, DAC C-052 "Cannabidiol" / NRF 22.10 "Oily cannabidiol solution 100 mg/ml")
Completed
- Comparative Bioavailability
- GLA-015
- DAC C-052 "Cannabidiol" / NRF 22.10 "Oily cannabidiol solution 100 mg/ml"
-
Erfurt, Thuringia, GermanySocraTec R&D GmbH Clinical Pharmacology Unit
Jul 12, 2021
COVID-19 Trial in Rio de Janeiro (Transcranial direct-current stimulation, Sham Transcranial direct-current stimulation)
Completed
- COVID-19
- Transcranial direct-current stimulation
- Sham Transcranial direct-current stimulation
-
Rio de Janeiro, RJ, BrazilD'Or Institute for Research and Education (IDOR)
Oct 13, 2021
Plaque Psoriasis Trial in Italy, Spain (Tildrakizumab 100 mg Solution for Injection)
Completed
- Plaque Psoriasis
- Tildrakizumab 100 mg Solution for Injection
-
Ancona, Italy
- +38 more
Feb 9, 2022
Atopic Dermatitis Trial in Germany, Poland (Lebrikizumab)
Recruiting
- Atopic Dermatitis
- Lebrikizumab
-
Darmstadt, Hessen, Germany
- +31 more
Jun 21, 2023
Covid19 Trial in Valencia (Betadine© bucal 100 mg/ml, Oximen® 3%, Clorhexidine Dental PHB©)
Completed
- Covid19
- Betadine© bucal 100 mg/ml
- +4 more
-
Valencia, SpainAlejandro Mira
Oct 6, 2021
Type 2 Diabetes, Renal Impairment Trial in Worldwide (Insulin glargine 300 U/mL, Insulin degludec 100 U/mL)
Recruiting
- Type 2 Diabetes Mellitus
- Renal Impairment
- Insulin glargine 300 U/mL
- Insulin degludec 100 U/mL
-
Yuma, Arizona
- +62 more
Dec 14, 2022
Pariet to Prevent Gastric and Duodenal Ulcer Associated With
Recruiting
- Stomach Ulcer
- Duodenal Ulcer
-
Cheongju, Chungcheongbuk-do, Korea, Republic of
- +28 more
Jan 13, 2022
Osteoarthritis of the Knee, Pain Trial in Worldwide (REGN5069, Matching Placebo)
Terminated
- Osteoarthritis of the Knee
- Pain
- REGN5069
- Matching Placebo
-
DeLand, Florida
- +11 more
Jun 10, 2021
COVID-19, SARS-CoV-2 Trial in Worldwide (AZD1222, AZD2816)
Active, not recruiting
- COVID-19
- SARS-CoV-2
- AZD1222
- AZD2816
-
Brasilia, Brazil
- +34 more
Jun 27, 2022
Painful Osteoarthritis of the Knee Trial in Worldwide (MEDI7352, Placebo)
Recruiting
- Painful Osteoarthritis of the Knee
- MEDI7352
- Placebo
-
Montclair, California
- +92 more
Aug 24, 2022
Pulmonary Disease, Chronic Obstructive Trial in Poland, Russian Federation, United States (FF/UMEC/VI, Tiotropium,
Completed
- Pulmonary Disease, Chronic Obstructive
- FF/UMEC/VI
- +7 more
-
Andalusia, Alabama
- +71 more
Jul 13, 2021
Symptomatic Neurogenic Orthostatic Hypotension, MSA, Parkinson's Disease (PD) Trial in Worldwide (ampreloxetine, Placebo)
Terminated
- Symptomatic Neurogenic Orthostatic Hypotension
- +3 more
- ampreloxetine
- Placebo
-
Sun City, Arizona
- +81 more
Dec 29, 2022
Foot Ulcer, Diabetic, Infection Trial in Worldwide (Gentamicin Collagen sponge, Placebo)
Completed
- Foot Ulcer, Diabetic
- Infection
- Gentamicin Collagen sponge
- Placebo
-
Anniston, Alabama
- +90 more
Sep 2, 2021
Type 2 Diabetes Trial in Worldwide (Bexagliflozin, Placebo for Bexagliflozin, Glimepiride)
Caries Trial in Padum Chak (Administration of sugar-free gums sugar-free gums containing 100% Xylitol as sweetener,
Not yet recruiting
- Caries
- Administration of sugar-free gums sugar-free gums containing 100% Xylitol as sweetener
- Administration of sugar-free gums sugar-free gums containing containing a polyols mixture plus a low amount of Xylitol (22%)
-
Padum Chak, IndiaCommunity Health Center, Dental Service,
Jun 3, 2020
Postmenopausal Osteoporosis Trial in Worldwide (FKS518, US-licensed Prolia)
Active, not recruiting
- Postmenopausal Osteoporosis
- FKS518
- US-licensed Prolia
-
Sofia, Sofia City, Bulgaria
- +75 more
Aug 29, 2022